For example, the MYH11 protein has a high magnitude of naCLIFI values for thymoma (<0) and prostate cancer (> 0) in all models, with the boosting models showing greater variability due to these predicting errors of prior trees. This evidence concerns the gene MYH11 and prostate cancer.